Navigation Links
Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019: Transparency Market Research
Date:10/1/2013

ALBANY, New York, October 1, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Blood Pressure Monitoring Testing Market (Sphygmomanometer, Automated Blood Pressure Monitors, Ambulatory Blood Pressure Monitors, Blood Pressure Transducers and Blood Pressure Instrument Accessories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is estimated to reach a market worth USD 3,661.3 million in 2019 at a CAGR of 11.5% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/blood-pressure-monitoring-market.html

Hypertension is one of the leading causes of heart diseases and strokes globally. The exact cause of high blood pressure is unknown but it develops with changing lifestyle and growing age. Rise in prevalence of high/low blood pressure is attributed to sedentary lifestyle, lack of physical activity geriatric population and rising stress. Blood pressure monitors are widely used by physicians in clinics, hospitals and even by patients themselves at home for self-monitoring. With the rising incidence rate of hypertension there is an increase in awareness about monitoring techniques, creating a substantial rise in demand for blood pressure monitoring devices. There are various social, behavioral and metabolic factors that determine and contribute to the development of high blood pressure (hypertension).

The blood pressure monitoring and testing market can be segmented as sphygmomanometers, automated blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, and blood pressure instrument accessories. Manufacturers are coming up with new and innovative digital blood pressure monitoring devices that are easy to use and provide accurate readings instantly. The digital sphygmomanometers market is expected to grow at a faster rate compared to other types of sphygmomanometers (mercury and aneroid) as they are easier to use and provide comparatively accurate results. Technological advancement is another important factor responsible for the growth of this market. mHealth is the new technological breakthrough in the healthcare market, where ubiquitous mobile technology supports the growth and successful implementation of mobile technology in healthcare industry. Prevention and early detection are the important factors for regular monitoring. Hence, mobile and portable devices would help the patient population to monitor their parameters. Devices when connected wirelessly would automatically transmit the required data of the patients to healthcare professionals.

The North American market accounted for the largest share of more than 40% in 2012 and is expected to dominate the market during the forecasted period. This accelerated growth is mainly due to rising population, sedentary lifestyle, increasing stress and changing lifestyles. It is estimated that one in every three Americans suffer from hypertension and an individual is three times more susceptible to heart diseases when suffering from hypertension. The Asia-Pacific region is expected to grow at the highest CAGR of over 12% from 2013 to 2019, due to expanding population base coupled with a sedentary lifestyle, triggering growth in this region. Prevalence of high blood pressure is more rampant in low or middle income countries as compared to high-income countries due to a growing number of people with undiagnosed, uncontrolled and untreated high blood pressure.

Related & Recently Published Reports by Transparency Market Research

The blood pressure monitoring testing market is presently witnessing intense competition from the key market players. To gain a proficient market share, manufacturers are coming up with cost effective, easy to use and innovative products. The prominent companies in the global blood pressure monitoring testing market include A&D Medical, GE Healthcare, Omron Healthcare, Philips Healthcare, SunTech Medical among others.

The Blood Pressure Monitoring Testing market is segmented as follows:

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... The two newest companies to join the University City Science ... out from The Wistar Institute, and Sanguis, launched by a trio of students from ... , Vironika is developing a treatment for a chronic viral infection and its associated ...
(Date:1/19/2017)... Research and Markets has announced the addition of the "Cancer ... Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. ... Cancer Biomarkers ... $15,737 million by 2022 from $6,521 in 2015, growing at a ... technologies segment accounted for more than half of the revenue share ...
(Date:1/19/2017)... , ... January 19, 2017 ... ... advanced software solutions for pharmaceutical research and development (R&D), today announced the ... omic data analysis and interpretation for the rapidly evolving field of precision ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical Informatics Association ... Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data sharing plans ... policy. AMIA recommended that NIH earmark funding for researchers to produce and execute ...
Breaking Biology Technology:
(Date:1/19/2017)... , Jan. 19, 2017 ... user experience and security for consumer electronics, and ... payment processing systems and cybersecurity solutions, today announced ... enterprises and financial institutions worldwide to bolster security ... the end-to-end secure user authentication platforms they offer, ...
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
(Date:1/12/2017)... SAN DIEGO , Jan. 12, 2017  Trovagene, ... circulating tumor DNA (ctDNA) technologies, today announced that it ... Europe and the Middle ... biopsy tests.  This milestone marks the first wave of ... tests for urine and blood samples. The ...
Breaking Biology News(10 mins):